Mkts

Orchestra BioMed Holdings, Inc.

NASDAQ: OBIO
$5.70-0.21 (-3.55%)
As of Nov 2, 1:31 PM ET

Key statistics

Day range
5.676.03
52-week range
3.466.50
Today
Open6.00
Previous close5.70
Volume—
Valuation
Market cap355.22M
P/E ratio—
EPS (TTM)-1.00
Income & risk
Dividend / yield—
Beta0.56
Avg volume366.0K
Discussion

OBIO News

Stories mentioning OBIO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue110.0030,917861.00836.00868.00253.00987.00778.00
Cost of Goods Sold32.0051.0049.0046.0044.0058.0068.0044.00
Gross Profit78.0030,866812.00790.00824.00195.00919.00734.00
Operating Expenses
Research & Development15,78116,82314,02713,85313,48210,97111,59511,126
Sales General & Admin6,3737,2897,0986,2646,2635,9015,6666,467
Total Operating Expenses
Operating Income (Loss)(22,076)6,754(20,313)(19,327)(18,921)(16,677)(16,342)(16,859)
Interest Income
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(20,691)6,245(20,828)(19,363)(18,755)(16,155)(15,426)(15,980)
Earnings Per Share (Basic)(0.33)0.13(0.40)(0.50)(0.49)(0.44)(0.41)(0.45)
Earnings Per Share (Diluted)(0.33)0.13(0.40)(0.50)(0.49)(0.44)(0.41)(0.45)
Weighted Average Shares Outstanding (Basic)62,72247,74752,18738,39338,23536,82137,62135,800
Weighted Average Shares Outstanding (Diluted)62,72247,74752,18738,39338,23536,82137,62135,800

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About OBIO

Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol OBIO. It last traded at $5.70 (Nov 2, 2026, 1:31 PM ET), down 3.5% on the day. That gives Orchestra BioMed a market capitalisation of $355.2M.

Over the past 52 weeks OBIO has traded between $3.46 and $6.50.

Revenue for the quarter ended Mar 31, 2026 was $110.0K; a net loss of $20.7M. Revenue was down 87.3% from $868.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$110.0K-$20.7M-18810.0%
Dec 31, 2025$30.9M$6.2M20.2%
Sep 30, 2025$861.0K-$20.8M-2419.0%
Jun 30, 2025$836.0K-$19.4M-2316.1%

From Orchestra BioMed’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…